Diseases and Conditions Treated with Hyperbaric Oxygen Therapy

conditions image

Acute Coronary Syndrome (ACS)

Definition and Causes

Acute coronary syndrome (ACS) is a blockage of the small blood vessels that supply the heart muscle with oxygen. ACS includes heart attack, called myocardial infarction, and chest pain or discomfort, called angina. People who experience heart attacks require immediate treatment by emergency medical personnel. Heart attacks often lead to sudden cardiac arrest or cardiac death.

ACS is caused by coronary artery disease (CAD), also called coronary heart disease (CHD). The most common type of heart disease, CAD is a narrowing of the small blood vessels that supply the heart with oxygen. The narrowed vessels may become clogged with blood clots or fat deposits circulating with the blood. Heart disease is the leading cause of death for both men and women in the US.

Hyperbaric Oxygen Approval Status

FDA Cleared: No Learn more about clearance
and approval status »
UHMS Approved: No

Treatment with Hyperbaric Oxygen Therapy

Hyperbaric oxygen therapy (HBOT) may reduce the risk of dying, the time to pain relief, and the chance of future heart attacks in people with acute coronary syndrome. HBOT increases the supply of oxygen to the heart and may decrease the area of damage and death in the heart muscle. More research is needed to confirm the efficacy of HBOT in conjunction with standard regimens and to identify the types of patients who may benefit the most.

hyperbariclink commentary

This page was created upon the publication of an updated meta-analysis [Cochrane Review, 2011] of 6 randomized controlled trials with 665 participants. This is uncommonly strong rationale for evidence-based hyperbaric medicine. The hyperbaric community sits up and takes notice when the Cochrane Collaboration, with its sterling reputation and rigorous literature review methodologies, reports such a compelling body of evidence. ACS is lacking the all-important pivotal clinical trial for FDA clearance. But soon the healthcare community may add acute coronary syndrome to the growing list of great reasons to demand 24/7 access to hyperbaric medicine.

Approved
FDA cleared, widely reimbursed
Compelling
Strong body of evidence
Promising
Repeatedly favorable results
Scant
Early or mixed results
None
Unfavorable or no evidence
Disproved
Strong evidence against HBOT

Learn more about Evidence Index ratings, the research we use, and how we assign scores »

Patient Resources

HyperbaricLink recommends the following websites for anyone seeking authoritative information, patient advocacy, and community support for acute coronary syndrome (ACS) and heart disease.

American Heart Association

With a mission to build healthier lives, free of cardiovascular diseases and stroke, the American Heart Association offers loads of information about ACS and heart disease, with especially fine patient resources through its HeartHub web portal.

Framingham Heart Study

Started in 1948, and now a project of the National Heart, Lung and Blood Institute and Boston University, the Framingham Heart Study has followed over 5,000 men and women and their offspring, spanning three generations, living in Framingham, Massachusetts. The study continues to help researchers identify the major risk factors of cardiovascular disease. The Framingham website includes risk score calculators and other tools for patients.

Clinical Resources

Start with the following resources to explore current research activities and the peer-reviewed medical literature on hyperbaric oxygen therapy for acute coronary syndrome (ACS).

ClinicalTrials.gov
National Institutes of Health

ClinicalTrials.gov keeps the official list of human clinical trials currently enrolling, in progress, and recently completed. One may reasonably question the size and legitimacy of any study not listed here.

Search ClinicalTrials.gov for current studies of coronary + heart + hyperbaric oxygen therapy

The Cochrane Collaboration

An independent, international, nongovernmental organization, the Cochrane Collaboration is a powerful force in evidence-based medicine. One may consider a Cochrane Reviews article on any HBOT topic required hyperbaric reading.

Read the Cochrane Reviews article Hyperbaric oxygen therapy for acute coronary syndrome

Google Scholar

A specialized Google search engine, Google Scholar indexes scholarly articles, patents, and legal opinions and journals. Google Scholar may generate excessive search results, but entries provide easy access to full-text journal articles.

Search Google Scholar for "retina" + "hyperbaric oxygen"

HBOEvidence

HBOEvidence uses computerized tools to appraise the key randomized controlled trials (RCTs) in the hyperbaric medical literature. One may reasonably question the overall strength of HBOT evidence for any disease or condition not covered here.

Read the HBOEvidence appraisals for treatment of myocardial ischemia with hyperbaric oxygen therapy.

PubMed.gov
US National Library of Medicine
National Institutes of Health

PubMed keeps the official list of scientific papers published in reputable peer-reviewed medical journals. One may reasonably question the importance and legitimacy of any study not listed here.

Related Terms

  • Angina
  • Cardiac arrest
  • Cardiovascular disease
  • Cholesterol
  • Coronary artery disease
  • Coronary thrombosis
  • Heart attack
  • Lipids
  • Lipoproteins
  • Myocardial infarction
  • Myocardial ischemia
  • Stroke
  • Sudden cardiac death
  • Unstable angina

News About Acute Coronary Syndrome and Hyperbaric Oxygen Therapy

More news from O2.0 – the HyperbaricLink blog


Complete acute coronary syndrome news archive from O2.0 — the HyperbaricLink blog

Further Reading

HyperbaricLink suggests HeartHub the American Heart Association's patient portal.

Sources
American Heart Association, Acute Coronary Syndrome. Retrieved 03 September 2011.
www.heart.org/HEARTORG/Conditions/HeartAttack/AboutHeartAttacks/Acute-Coronary-Syndrome_UCM_428752_Article.jsp
Bennett MH, Lehm JP, Jepson N. Hyperbaric oxygen therapy for acute coronary syndrome.
Cochrane Database of Systematic Reviews 2011,
Issue 8. Art. No.: CD004818. DOI: 10.1002/14651858.CD004818.pub3. Retrieved 31 August 2011.
www2.cochrane.org/reviews/en/ab004818.html
Page Data
Updated: 03 Sep 2011 06:41 PM
Created: 03 Sep 2011 11:12 AM
By: About the authors »